Filtrar por género

Everything GLP-1

Everything GLP-1

NINETY EIGHT STUDIOS

Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr. Tom Lavin as he engages in conversations with industry experts to help you feel more confident and inspired to live a fuller life on your terms.


For more questions on GLP-1s and if they're right for you, visit YourEra.com


DISCLAIMER: Dr. Lavin's podcast is for informational and entertainment purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making decisions about your health.

Hosted on Acast. See acast.com/privacy for more information.

13 - Counseling Patients Through Weight Loss and Mental Health with Cassidy Palmisano
0:00 / 0:00
1x
  • 13 - Counseling Patients Through Weight Loss and Mental Health with Cassidy Palmisano

    In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Cassidy Palmisano, a licensed professional counselor with a master's in clinical mental health counseling and roughly a decade of experience across inpatient and outpatient settings, to examine the relationship between obesity and mental health. Rather than treating weight loss and emotional wellbeing as separate concerns, the conversation frames them as deeply interconnected, with GLP-1 medications acting as a tool that removes long-standing barriers to change.


    Together, they discuss how the biology of obesity has historically been misread as a failure of willpower, and how easing that burden opens space for patients to address depression, anxiety, and past trauma that food struggles had long overshadowed. Cassidy explains how reduced compulsive behavior and diminished food noise can restore a sense of agency, allowing patients to reconnect with what is meaningful in their lives.


    It is a thoughtful discussion for clinicians, mental health professionals, and anyone interested in how physical and psychological care intersect in the treatment of obesity.


    [00:00] Welcome and Meet Cassidy Palmisano

    [02:36] Why Healthcare Works in Silos

    [06:57] Obesity as Biology, Not Willpower

    [11:26] Opening Space for Mental Health Work

    [19:51] Self-Acceptance Without Complacency

    [24:57] Building the Whole-Person Approach

    [35:10] Peptides, Inflammation, and What's Next


    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 02 Sep 2026 - 43min
  • 12 - Managing GLP-1 Side Effects Through Smart Eating with Amy Davis

    In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Amy Davis, a registered dietitian with ten years of experience helping patients optimize their nutrition and health, to explore how food choices shape outcomes for people on GLP-1 medications. Nutrition is often treated as an afterthought once a prescription is written, but the conversation makes clear that what patients eat directly influences muscle preservation, side effect management, and long-term success.


    Amy explains her three non-negotiables, protein, non-starchy vegetables, and fiber, and why each becomes more critical as calorie intake drops. Together, they discuss practical strategies for hitting protein goals, managing constipation and other GI symptoms tied to slowed digestion, and recognizing ultra-processed foods without falling into all-or-nothing thinking.


    It is a practical, evidence-grounded discussion for clinicians, patients, and anyone seeking sustainable, real-world nutrition strategies to complement GLP-1 therapy.


    [00:00] Welcome and Introduction to Amy Davis

    [02:25] The Three Nutrition Non-Negotiables

    [06:46] Protein Goals and Easy Sources

    [13:10] Balanced Plates and Healthy Carbs

    [14:02] Fiber, Gut Health, and GI Side Effects

    [19:31] Fasting, Weightlifting, and Realistic Goals

    [23:26] Spotting and Avoiding Ultra-Processed Foods

    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 19 Aug 2026 - 34min
  • 11 - Why Sourcing and Testing Matter in Compounded Peptides | Trey (Joseph) Pierre

    In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Trey (Joseph) Pierre, who heads Galleria Medical Pharmacy in New Orleans and ranks among the top compounding pharmacists in the Gulf South, to trace how compounding has evolved from mortar-and-pestle apothecary work into a heavily regulated science built on sterility testing, potency verification, and sourcing from FDA-registered facilities.


    Trey explains how oversight from the United States Pharmacopeia reshaped the industry after early safety failures, and together they draw a sharp line between legitimate 503 pharmacies and the unregulated gray and black markets supplying peptides with no quality assurance or physician oversight. They also discuss why personalized, customized medications are central to the future of preventive, patient-centered care.


    It is a timely discussion for clinicians, healthcare leaders, and patients who want to understand what separates safe, accountable compounding from the risks lurking in unregulated peptide sourcing.


    [00:00] Introducing Trey Pierre and Galleria Pharmacy

    [01:01] From Mortar and Pestle to Modern Compounding

    [03:13] Rising Standards in Today's Industry

    [06:59] The Dangers of the Black Market

    [09:24] Category 1, Category 2, and FDA Oversight

    [12:41] The Case for Personalized Medicine

    [21:10] What's Next for Galleria Medical Pharmacy


    DISCLAIMER: Dr. Lavin's podcast is for informational and entertainment purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making decisions about your health.



    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 05 Aug 2026 - 22min
  • 10 - Inside the Regulatory Battle Shaping Compounded GLP-1 Access | Scott Brunner

    In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Scott Brunner, CEO and President of the Alliance for Pharmacy Compounding, to examine how pharmacy compounding has shaped patient access during the GLP-1 shortage era. Rather than framing compounding as a workaround, Brunner explains how it operates within a rigorous, multilayered regulatory system involving the FDA, USP standards, and state boards of pharmacy.


    Together, they discuss how drug makers have sometimes conflated legitimate compounding with counterfeit activity, the growing black market for unapproved peptides, and why personalized, prescriber-directed formulations remain essential for patients whose needs fall outside commercially available options. Brunner also outlines the case for creating a regulated pathway for peptide compounding, including enhanced safety data collection.


    Listeners will come away with a clearer understanding of how compounding regulation actually works, why it matters for patient safety and access, and what policy changes may be coming. It is a valuable listen for clinicians, healthcare leaders, and anyone following the future of GLP-1 access and obesity medicine.


    DISCLAIMER: Dr. Lavin's podcast is for informational and entertainment purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making decisions about your health.

    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 22 Jul 2026 - 33min
  • 9 - Everything You Need to Know About Compounded GLP-1s in 2026 | Karla Palmer

    Compounded GLP-1 medications have become one of the most talked-about topics in healthcare, but there’s also a tremendous amount of confusion surrounding their legality, safety, and role in patient care. In this episode of Everything GLP-1, Dr. Tom Lavin sits down with Karla Palmer, one of the nation’s leading FDA and DEA regulatory attorneys, to break through the misinformation and explain what patients need to know.

    With more than three decades of experience advising pharmacies, manufacturers, and healthcare providers, Karla explains how compounded medications have been a vital part of American healthcare for decades, why 503A compounding pharmacies exist, and what changed after the GLP-1 shortages officially ended. Together, they discuss the important differences between legally compounded medications and unregulated research peptides, how patients can identify safe sources of treatment, and why physician oversight remains essential.

    Whether you’re currently taking a GLP-1, considering treatment, or simply trying to understand the rapidly changing landscape, this conversation offers clear, practical insight into the future of compounded GLP-1s, peptide therapies, and FDA regulation. It’s an essential episode for anyone who wants to make informed decisions about their health with facts instead of headlines.


    https://www.yourera.com/

    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 08 Jul 2026 - 44min
Mostrar más episodios

Podcasts similares a Everything GLP-1